Funder: Wellcome Trust
Due Dates: June 2, 2026 (Full application, 15:00 BST)
Funding Amounts: £1,000,000–£8,000,000 per award | 3–5 years | 8–12 awards expected
Summary: Supports transdisciplinary teams led from Africa, South Asia, or South-East Asia to conduct randomised controlled trials optimising licensed pharmaceutical interventions for infectious diseases, aiming for policy and practice impact in low- and middle-income countries.
Key Information: Lead and at least one coapplicant must be based in Africa, South Asia, or South-East Asia; strict eligibility and scope requirements apply.